Novartis is a leading global healthcare company headquartered in Switzerland, renowned for its commitment to reimagining medicine and improving patient outcomes. With a presence in over 140 countries, Novartis focuses on innovative pharmaceuticals and cutting-edge research that address some of the world’s most challenging health issues.
Singapore plays a strategic role in Novartis’ global operations. As a regional hub for commercial, manufacturing, and research activities, Novartis Singapore contributes significantly to the company’s mission in Asia Pacific. With a strong local presence and investment in talent and infrastructure, Novartis is not only advancing healthcare innovation in the region but also supporting Singapore’s vision to be a leading biomedical science hub.
Fun Fact: Global Collaboration: Novartis & Pfizer
Novartis and Pfizer, two of the world’s largest pharmaceutical companies, have collaborated on several fronts over the years — from joint ventures in drug development to strategic manufacturing partnerships. One notable example is their co-development and commercialization efforts in areas like oncology and rare diseases, where shared expertise accelerates innovation and expands patient access to life-saving treatments. Especially during critical periods like the COVID-19 pandemic, both companies played pivotal roles.
We’re proud to have worked with both Novartis and Pfizer on their signage needs, supporting their branding presence in Singapore.
This project involved the fabrication and installation of two sets of external building signs, each carefully tailored to enhance brand visibility while aligning with Novartis’ corporate identity guidelines.
Novartis approached us with a clear vision — to reinforce their brand presence at their Singapore location with sleek, high-impact building signage. Our goal was to deliver signage that was not only visually striking but also durable and compliant with local building and safety regulations.
After a series of design reviews and site assessments, the final scope involved the creation of two sets of front lit building signs strategically positioned to ensure visibility from multiple vantage points; also with high-quality materials and skilled technical planning of the mounting details.
Our team conducted careful planning and coordination to minimise disruption during installation. Weatherproofing and structural safety were also key concerns, given the signage’s exposure to the elements. We ensured all installations complied with local codes and performed rigorous quality checks post-installation.
The completed signage now stands as a prominent visual marker for Novartis in Singapore — a fusion of thoughtful design, expert craftsmanship, and brand integrity. Both signs reflect the company’s global presence while complementing the simple architectural form of the building.
Novartis is located at 8 Tuas Bay, while Novartis BioPharmOps is located at 40 Tuas South.
We’re proud to have supported Novartis in strengthening their brand identity through quality signage solutions. Projects like these continue to inspire us to deliver excellence in every detail, from design to final installation.
If you’re looking to elevate your corporate signage, get in touch with our team — we’d love to help bring your brand to life with your building signage.
Fill up the contact form if you need help with your signage recommendation!
-
Melissa Tan
Follow our Socials now !
